NASDAQ
Mirati Therapeutics, Inc. (MRTX) has a fcf yield of -22.58% as of Friday, May 29, 2026. This represents a 448.21% decrease compared to its 12-month average of -4.12%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.